Stay updated on Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Locations section added showing Florida as a study site; Florida Locations entry and the HHS Vulnerability Disclosure link were removed. Revision: v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T22:23:04.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision history updated: added v3.3.2 and removed v3.2.0; no changes to the study content.
    Difference
    0.0%
    Check dated 2025-11-25T11:48:32.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page. The study details and related information remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T07:14:09.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now displays sponsor-related entries such as the H. Lee Moffitt Cancer Center and Research Institute and includes a 'Helpful Links Provided by' section with a link to the Moffitt Clinical Trials site. This enhances access to sponsor resources and related trial information on the study page.
    Difference
    0.1%
    Check dated 2025-11-11T02:57:54.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    No significant changes to the study details were detected between versions; any differences are likely cosmetic formatting or layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:20:17.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Update introduces newer date stamps and an estimated last-update label, while removing older date references and a prior last-update cue.
    Difference
    0.4%
    Check dated 2025-10-13T11:51:25.000Z thumbnail image

Stay in the know with updates to Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page.